Hermes Florez to Blood Glucose
This is a "connection" page, showing publications Hermes Florez has written about Blood Glucose.
Connection Strength
2.760
-
Glycaemic control and glycaemic variability in older people with diabetes. Lancet Diabetes Endocrinol. 2018 06; 6(6):433-435.
Score: 0.479
-
How to prevent the microvascular complications of type 2 diabetes beyond glucose control. BMJ. 2017 Jan 17; 356:i6505.
Score: 0.439
-
Metabolic syndrome components and their response to lifestyle and metformin interventions are associated with differences in diabetes risk in persons with impaired glucose tolerance. Diabetes Obes Metab. 2014 Apr; 16(4):326-33.
Score: 0.351
-
Intensive Glucose Control in Patients with Type 2 Diabetes - 15-Year Follow-up. N Engl J Med. 2019 Jun 06; 380(23):2215-2224.
Score: 0.259
-
Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2015 Jun 04; 372(23):2197-206.
Score: 0.196
-
Optimization of Metformin in the GRADE Cohort: Effect on Glycemia and Body Weight. Diabetes Care. 2020 05; 43(5):940-947.
Score: 0.136
-
Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009 Jan 08; 360(2):129-39.
Score: 0.125
-
Metformin and ageing: improving ageing outcomes beyond glycaemic control. Diabetologia. 2017 09; 60(9):1630-1638.
Score: 0.114
-
Confirming glycemic status in the Diabetes Prevention Program: implications for diagnosing diabetes in high risk adults. J Diabetes Complications. 2013 Mar-Apr; 27(2):150-7.
Score: 0.082
-
Impact of lifestyle intervention and metformin on health-related quality of life: the diabetes prevention program randomized trial. J Gen Intern Med. 2012 Dec; 27(12):1594-601.
Score: 0.080
-
Long work hours is associated with suboptimal glycemic control among US workers with diabetes. Am J Ind Med. 2011 May; 54(5):375-83.
Score: 0.072
-
Association of Baseline Characteristics With Insulin Sensitivity and ?-Cell Function in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) Study Cohort. Diabetes Care. 2021 02; 44(2):340-349.
Score: 0.072
-
Rationale and Design for a GRADE Substudy of Continuous Glucose Monitoring. Diabetes Technol Ther. 2019 12; 21(12):682-690.
Score: 0.066
-
Black Hispanics have a worse cardiovascular risk profile than mixed Hispanics in Venezuela. Invest Clin. 2007 Mar; 48(1):45-55.
Score: 0.055
-
Suitable Use of Injectable Agents to Overcome Hypoglycemia Risk, Barriers, and Clinical Inertia in Community-Dwelling Older Adults with Type 2 Diabetes Mellitus. Drugs Aging. 2019 12; 36(12):1083-1096.
Score: 0.033
-
Baseline Characteristics of Randomized Participants in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE). Diabetes Care. 2019 11; 42(11):2098-2107.
Score: 0.033
-
Women relatives of Hispanic patients with type 2 diabetes are more prone to exhibit metabolic disturbances. Invest Clin. 1999 Jun; 40(2):127-42.
Score: 0.032
-
A Randomized Controlled Trial Comparing Efficacy and Safety of Insulin Glargine 300 Units/mL Versus 100 Units/mL in Older People With Type 2 Diabetes: Results From the SENIOR Study. Diabetes Care. 2018 08; 41(8):1672-1680.
Score: 0.030
-
Metformin, Lifestyle Intervention, and Cognition in the Diabetes Prevention Program Outcomes Study. Diabetes Care. 2017 07; 40(7):958-965.
Score: 0.028
-
Management of Diabetes in Long-term Care and Skilled Nursing Facilities: A Position Statement of the American Diabetes Association. Diabetes Care. 2016 Feb; 39(2):308-18.
Score: 0.026
-
[Dyslipidemia and hyperinsulinemia in normoglycemic-obese relatives of patients with non-insulin dependent diabetes mellitus]. Invest Clin. 1995 Sep; 36(3):131-47.
Score: 0.025
-
Rosiglitazone treatment and cardiovascular disease in the Veterans Affairs Diabetes Trial. Diabetes Obes Metab. 2015 Oct; 17(10):949-55.
Score: 0.025